Israel Englander Editas Medicine, Inc. Put Options Transaction History
Millennium Management LLC
- $192 Billion
- Q2 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding EDIT
# of Institutions
220Shares Held
45.5MCall Options Held
393KPut Options Held
354K-
Black Rock Inc. New York, NY7.78MShares$17.8 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.16MShares$16.4 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA1.96MShares$4.5 Million0.0% of portfolio
-
State Street Corp Boston, MA1.85MShares$4.23 Million0.0% of portfolio
-
Pictet Asset Management Sa Geneva 73, V81.61MShares$3.69 Million0.02% of portfolio
About Editas Medicine, Inc.
- Ticker EDIT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 68,737,200
- Market Cap $157M
- Description
- Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...